Question

A 58-year-old with multiple recurrences of C. difficile after guideline therapies asks about monoclonal antibody option. Which is correct?

Accepted Answer

Bezlotoxumab is given with standard-of-care antibiotics to reduce recurrence

Answer

Bezlotoxumab is given alone to treat acute CDI

Answer

Bezlotoxumab replaces FMT

Answer

Bezlotoxumab is contraindicated in heart failure

Answer

Probiotics are equivalent to bezlotoxumab

Practice question

A 58-year-old with multiple recurrences of C. difficile after guideline therapies asks about monoclonal antibody option. Which is correct?